269 related articles for article (PubMed ID: 14999630)
1. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.
Patel VB; Padayatchi N; Bhigjee AI; Allen J; Bhagwan B; Moodley AA; Mthiyane T
Clin Infect Dis; 2004 Mar; 38(6):851-6. PubMed ID: 14999630
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.
Padayatchi N; Bamber S; Dawood H; Bobat R
Pediatr Infect Dis J; 2006 Feb; 25(2):147-50. PubMed ID: 16462292
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
4. Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis.
Sofia M; Maniscalco M; Honoré N; Molino A; Mormile M; Heym B; Cole ST
Int J Tuberc Lung Dis; 2001 Jun; 5(6):551-8. PubMed ID: 11409583
[TBL] [Abstract][Full Text] [Related]
5. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
6. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of Mycobacterium tuberculosis causing multidrug-resistant tuberculosis meningitis.
Caws M; Thwaites GE; Duy PM; Tho DQ; Lan NT; Hoa DV; Chau TT; Huyen MN; Anh PT; Chau NV; Chinh TN; Stepniewska K; Farrar J
Int J Tuberc Lung Dis; 2007 Feb; 11(2):202-8. PubMed ID: 17263292
[TBL] [Abstract][Full Text] [Related]
8. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
11. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.
Ejigu GS; Woldeamanuel Y; Shah NS; Gebyehu M; Selassie A; Lemma E
Int J Tuberc Lung Dis; 2008 Mar; 12(3):332-7. PubMed ID: 18284841
[TBL] [Abstract][Full Text] [Related]
12. Drug susceptibility profiling of tuberculous meningitis.
Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
[TBL] [Abstract][Full Text] [Related]
13. [Process of acquiring drug resistance: retrospective review of records of MDR TB].
Yoshiyama T; Ito K; Ogata H; Mitarai S; Hoshino H; Okumura M; Aman K; Aono A; Wada M
Kekkaku; 2004 Dec; 79(12):717-24. PubMed ID: 15782617
[TBL] [Abstract][Full Text] [Related]
14. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of acquired MDR-TB and HIV co-infection.
Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
[TBL] [Abstract][Full Text] [Related]
17. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for drug resistant tuberculosis in southeast Turkey.
Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F
Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
[TBL] [Abstract][Full Text] [Related]
19. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
Timperi R; Han LL; Sloutsky A; Becerra MC; Nardell EA; Salazar JJ; Smith-Fawzi MC
Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
